Metabolomics is the large-scale study of metabolites, the small molecules such as sugars, fats and amino acids that cells produce and consume. Where genomics describes what an organism's genes could do and proteomics catalogues its proteins, metabolomics records the chemical activity actually under way in a sample of blood, urine or tissue at one moment. Measurements are made mainly by mass spectrometry and nuclear magnetic resonance. Metabolite levels shift within minutes in response to diet, drugs and disease, which makes them a sensitive but variable signal.
The field is used to find markers for the early detection of disease, to study how drugs act and to develop molecular diagnostics. It is one layer of multiomics. For investors it is a niche within life-science tools and diagnostics, reached mostly through instrument makers and testing companies, and it features in thematic investing funds built around precision medicine and longevity. Commercial success depends on clinical validation, regulatory approval and reimbursement.